Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · IEX Real-Time Price · USD
0.725
+0.025 (3.63%)
At close: May 1, 2024, 4:00 PM
0.726
0.00 (0.06%)
Pre-market: May 2, 2024, 5:01 AM EDT
CMMB's stock price has decreased by -51.48% in the past year and price targets may not have had time to catch up.
Chemomab Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$7.00
Upside
+864.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Mar 8, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +864.98% | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +864.98% | Oct 6, 2023 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $12 → $7 | Buy | Maintains | $12 → $7 | +864.98% | Apr 18, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +2,657.10% | Mar 10, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 7, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 26, 2021 |
| Oppenheimer | Oppenheimer | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 7, 2021 |